{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:08:58Z","timestamp":1789070938771,"version":"build-2803163510"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA006516"],"award-info":[{"award-number":["P30 CA006516"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K08 CA282969"],"award-info":[{"award-number":["K08 CA282969"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009779","name":"Bladder Cancer Advocacy Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009779","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Karin Grunebaum Cancer Research Foundation"},{"DOI":"10.13039\/501100014434","name":"Polish National Agency for Academic Exchange","doi-asserted-by":"publisher","award":["BPN\/WAL\/2024\/1\/00014"],"award-info":[{"award-number":["BPN\/WAL\/2024\/1\/00014"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Agency in Poland","award":["2023\/ABM\/02\/00009"],"award-info":[{"award-number":["2023\/ABM\/02\/00009"]}]},{"name":"Medical University of Lodz Digital Medicine Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumor-only whole-exome sequencing (WES) is used when matched normal tissue is unavailable, but one sample can produce thousands of variants. Somatic likelihood tiering (SLT) is an interpretable post-calling protocol that ranks Mutect2 calls into four review-priority tiers using population-frequency, germline-quality, cancer-knowledge, PureCN posterior, and clonal-hematopoiesis evidence. Layer 2 distinguishes common, rare-callable, and unevaluable gnomAD states; missing or unmatchable gnomAD evidence is not positive rarity evidence. On the SEQC2 HCC1395 benchmark, the callability-aware SLT-A row contained 101 calls, 78 truth variants, 77.2% PPV (95% Wilson confidence interval 68.1%\u201384.3%), and a Number Needed to Review (NNR) of 1.29 (1.19\u20131.47). The conservative SLT-C catchment retained 352 of 455 truth variants (77.4%, 73.3%\u201381.0%) and all tiers together retained 430 of 455 truth variants. SNV performance is the primary calibration frame: SLT-C retained 341 of 439 SNV truth variants, whereas indel results were exploratory because only 16 truth indels were available. Clinical cohorts are reported as recall and concordance versus partially dependent matched-normal Mutect2 references, not independent clinical sensitivity. Patient-level bootstrap intervals were principal: HdM-BLCA-1 SLT-A recall was 18.2% (14.0%\u201323.5%), and LUAD-TW SLT-A recall was 49.1% (26.6%\u201363.3%) among 32 evaluable patients. The HdM-BLCA-1 median SLT-A queue remained 1277 variants per patient, so SLT reduces first-pass candidate counts but does not measure review time or eliminate FFPE candidate-count burden. SLT provides an auditable tumor-only WES review queue, not a substitute for matched-normal sequencing, independent orthogonal validation, or definitive somatic classification.<\/jats:p>","DOI":"10.1093\/bib\/bbag487","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:51:15Z","timestamp":1787140275000},"source":"Crossref","is-referenced-by-count":0,"title":["Somatic likelihood tiering: an interpretable post-calling triage protocol for tumor-only whole-exome variant review"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6550-3384","authenticated-orcid":false,"given":"Konrad","family":"Stawiski","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute , 450 Brookline Ave., 02215 Boston, MA,","place":["United States"]},{"name":"Department of Biostatistics and Translational Medicine, Medical University of Lodz , Mazowiecka 15, 92-215 Lodz ,","place":["Poland"]},{"name":"Department of Urology, Brigham and Women\u2019s Hospital , 75 Francis St., 02115 Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9283-6515","authenticated-orcid":false,"given":"Sophia C","family":"Kamran","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mass General Brigham , 800 Boylston St., 02199 Boston, MA ,","place":["United States"]},{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital , 75 Francis St., 02115 Boston, MA ,","place":["United States"]},{"name":"Harvard Medical School , 25 Shattuck St., 02115 Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6809-132X","authenticated-orcid":false,"given":"J\u00falia","family":"Perera-Bel","sequence":"additional","affiliation":[{"name":"PSMAR Hospital del Mar Medical Research Institute (IMIM) , Carrer del Doctor Aiguader, 88, Ciutat Vella, 08003 Barcelona ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6002-8038","authenticated-orcid":false,"given":"Jihyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital , 75 Francis St., 02115 Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7569-7074","authenticated-orcid":false,"given":"Joaquim","family":"Bellmunt","sequence":"additional","affiliation":[{"name":"Harvard Medical School , 25 Shattuck St., 02115 Boston, MA ,","place":["United States"]},{"name":"PSMAR Hospital del Mar Medical Research Institute (IMIM) , Carrer del Doctor Aiguader, 88, Ciutat Vella, 08003 Barcelona ,","place":["Spain"]},{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute , 450 Brookline Ave., 02115 Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7939-7343","authenticated-orcid":false,"given":"Kent W","family":"Mouw","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Dana-Farber Cancer Institute , 450 Brookline Ave., 02215 Boston, MA,","place":["United States"]},{"name":"Harvard Medical School , 25 Shattuck St., 02115 Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2378-6512","authenticated-orcid":false,"given":"Filipe L F","family":"De Carvalho","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital , 75 Francis St., 02115 Boston, MA ,","place":["United States"]},{"name":"Harvard Medical School , 25 Shattuck St., 02115 Boston, MA ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"2026091015393349300_ref1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1200\/CCI.19.00130","article-title":"Reliable analysis of clinical tumor-only whole-exome sequencing data","volume":"4","author":"Oh","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"key":"2026091015393349300_ref2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.annonc.2022.12.003","article-title":"Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO precision medicine working group recommendations","volume":"34","author":"Kuzbari","year":"2023","journal-title":"Ann Oncol"},{"key":"2026091015393349300_ref3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"2026091015393349300_ref4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","article-title":"A genomic mutational constraint map using variation in 76,156 human genomes","volume":"625","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"2026091015393349300_ref5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13029-016-0060-z","article-title":"PureCN: copy number calling and SNV classification using targeted short read sequencing","volume":"11","author":"Riester","year":"2016","journal-title":"Source Code Biol Med"},{"key":"2026091015393349300_ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02839-x","article-title":"Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic","author":"Park","year":"2025","journal-title":"Nat Biotechnol"},{"key":"2026091015393349300_ref7","doi-asserted-by":"publisher","first-page":"9630","DOI":"10.1038\/s41467-025-64547-z","article-title":"ClairS-TO: a deep-learning method for long-read tumor-only somatic small variant calling","volume":"16","author":"Chen","year":"2025","journal-title":"Nat Commun"},{"key":"2026091015393349300_ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-71705-4","article-title":"Improved tumor-only variant calling and mutation burden estimation with VarNet-T","volume":"17","author":"Krishnamachari","journal-title":"Nat Commun"},{"key":"2026091015393349300_ref9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41698-022-00340-1","article-title":"Fast, accurate, and racially unbiased pan-cancer tumor-only variant calling with tabular machine learning","volume":"7","author":"McLaughlin","year":"2023","journal-title":"npj Precis Oncol"},{"key":"2026091015393349300_ref10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41698-021-00164-5","article-title":"Inflation of tumor mutation burden by tumor-only sequencing in under-represented groups","volume":"5","author":"Asmann","year":"2021","journal-title":"npj Precis Oncol"},{"key":"2026091015393349300_ref11","first-page":"61","article-title":"A method to reduce ancestry related germline false positives in tumor only somatic variant calling","volume":"10","author":"Halperin","year":"2017","journal-title":"BMC Med Genet"},{"key":"2026091015393349300_ref12","doi-asserted-by":"crossref","first-page":"bbae677","DOI":"10.1093\/bib\/bbae677","article-title":"Precise identification of somatic and germline variants in the absence of matched normal samples","volume":"26","author":"Li","year":"2024","journal-title":"Brief Bioinform"},{"key":"2026091015393349300_ref13","doi-asserted-by":"crossref","first-page":"e1005965","DOI":"10.1371\/journal.pcbi.1005965","article-title":"A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal","volume":"14","author":"Sun","year":"2018","journal-title":"PLoS Comput Biol"},{"key":"2026091015393349300_ref14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13073-017-0446-9","article-title":"ISOWN: accurate somatic mutation identification in the absence of normal tissue controls","volume":"9","author":"Kalatskaya","year":"2017","journal-title":"Genome Med"},{"key":"2026091015393349300_ref15","first-page":"zcab040","article-title":"UNMASC: tumor-only variant calling with unmatched normal controls. NAR","volume":"3","author":"Little","year":"2021","journal-title":"Cancer"},{"key":"2026091015393349300_ref16","doi-asserted-by":"crossref","first-page":"vbac070","DOI":"10.1093\/bioadv\/vbac070","article-title":"TOSCA: an automated tumor only somatic CAlling workflow for somatic mutation detection without matched normal samples","volume":"2","author":"Del Corvo","year":"2022","journal-title":"Bioinform Adv"},{"key":"2026091015393349300_ref17","doi-asserted-by":"crossref","first-page":"btae121","DOI":"10.1093\/bioinformatics\/btae121","article-title":"ArCH: improving the performance of clonal hematopoiesis variant calling and interpretation","volume":"40","author":"Chan","year":"2024","journal-title":"Bioinformatics"},{"key":"2026091015393349300_ref18","doi-asserted-by":"crossref","first-page":"qzaf040","DOI":"10.1093\/gpbjnl\/qzaf040","article-title":"UNISOM: unified somatic calling and machine learning-based classification enhance the discovery of CHIP","volume":"23","author":"Tian","year":"2025","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2026091015393349300_ref19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"2026091015393349300_ref20","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: the catalogue of somatic mutations In cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"2026091015393349300_ref21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC cancer gene census: describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2026091015393349300_ref22","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"2026091015393349300_ref23","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"key":"2026091015393349300_ref24","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-020-00710-0","article-title":"Cancer therapy shapes the fitness landscape of clonal hematopoiesis","volume":"52","author":"Bolton","year":"2020","journal-title":"Nat Genet"},{"key":"2026091015393349300_ref25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2026091015393349300_ref26","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41587-021-00993-6","article-title":"Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing","volume":"39","author":"Fang","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2026091015393349300_ref27","unstructured":"BostonGene . Extended somatic reference standards of model cancer cell lines. Zenodo \u00a02024. 10.5281\/zenodo.15261589 \u00a0BioProject PRJNA1134786 (12 May 2026, date last accessed)"},{"key":"2026091015393349300_ref28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cels.2018.03.002","article-title":"Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines","volume":"6","author":"Ellrott","year":"2018","journal-title":"Cell Syst"},{"key":"2026091015393349300_ref29","doi-asserted-by":"crossref","first-page":"15287","DOI":"10.1038\/s41598-023-42495-2","article-title":"The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer","volume":"13","author":"Boll","year":"2023","journal-title":"Sci Rep"},{"key":"2026091015393349300_ref30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.12688\/f1000research.16665.2","article-title":"Sarek: a portable workflow for whole-genome sequencing analysis of germline and somatic variants","volume":"9","author":"Garcia","year":"2020","journal-title":"F1000Research"},{"key":"2026091015393349300_ref31","doi-asserted-by":"crossref","first-page":"107352","DOI":"10.1016\/j.lungcan.2023.107352","article-title":"Whole exome sequencing and microRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages","volume":"184","author":"Ho","year":"2023","journal-title":"Lung Cancer"},{"key":"2026091015393349300_ref32","doi-asserted-by":"publisher","DOI":"10.1101\/861054","article-title":"Calling somatic SNVs and indels with Mutect2","author":"Benjamin","year":"2019"},{"key":"2026091015393349300_ref33","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkw227","article-title":"VarDict: a novel and versatile variant caller for next-generation sequencing in cancer research","volume":"44","author":"Lai","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026091015393349300_ref34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng.3774","article-title":"CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer","volume":"49","author":"Griffith","year":"2017","journal-title":"Nat Genet"},{"key":"2026091015393349300_ref35","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"1","author":"Chakravarty","journal-title":"JCO Precis Oncol"},{"key":"2026091015393349300_ref36","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cell.2018.02.060","article-title":"Comprehensive characterization of cancer driver genes and mutations","volume":"173","author":"Bailey","year":"2018","journal-title":"Cell"},{"key":"2026091015393349300_ref37","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1056\/NEJMoa2413361","article-title":"Tumor-infiltrating clonal hematopoiesis","volume":"392","author":"Pich","year":"2025","journal-title":"N Engl J Med"},{"key":"2026091015393349300_ref38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"key":"2026091015393349300_ref39","doi-asserted-by":"publisher","first-page":"bbae697","DOI":"10.1093\/bib\/bbae697","article-title":"A benchmarking study of individual somatic variant callers and voting-based ensembles for whole-exome sequencing","volume":"26","author":"Guille","year":"2025","journal-title":"Brief Bioinform"},{"key":"2026091015393349300_ref40","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"2026091015393349300_ref41","doi-asserted-by":"publisher","first-page":"e082505","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","year":"2025","journal-title":"BMJ"},{"key":"2026091015393349300_ref42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13073-018-0529-2","article-title":"From somatic variants towards precision oncology: evidence-driven reporting of treatment options in molecular tumor boards","volume":"10","author":"Perera-Bel","year":"2018","journal-title":"Genome Med"},{"key":"2026091015393349300_ref43","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.annonc.2024.04.005","article-title":"Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO precision medicine working group","volume":"35","author":"Mosele","year":"2024","journal-title":"Ann Oncol"},{"key":"2026091015393349300_ref44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.annonc.2025.02.009","article-title":"ESMO precision oncology working group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice","volume":"36","author":"Westphalen","year":"2025","journal-title":"Ann Oncol"},{"key":"2026091015393349300_ref45","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ccell.2022.08.022","article-title":"Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors","volume":"40","author":"Nassar","year":"2022","journal-title":"Cancer Cell"},{"key":"2026091015393349300_ref46","doi-asserted-by":"crossref","first-page":"1361317","DOI":"10.3389\/fmed.2024.1361317","article-title":"Identification of germline population variants misclassified as cancer-associated somatic variants","volume":"11","author":"Pollard","year":"2024","journal-title":"Front Med"},{"key":"2026091015393349300_ref47","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Mak"},{"key":"2026091015393349300_ref48","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41512-019-0064-7","article-title":"A simple, step-by-step guide to interpreting decision curve analysis","volume":"3","author":"Vickers","year":"2019","journal-title":"Diagn Progn Res"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/27\/5\/bbag487\/71022368\/bbag487.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/27\/5\/bbag487\/71022368\/bbag487.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:39:45Z","timestamp":1789069185000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbag487\/8790179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbag487","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9,1]]},"article-number":"bbag487"}}